Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12175690

Download in:

View as

General Info

PMID
12175690